Prostate cancer poorly differentiated adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Cardia Epithelial Cells Neoplastic Stem Cells Esophagogastric Junction Chromosomes, Human, Pair 8 Seminal Vesicles Stromal Cells Rectum Cell Line

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases51

Adenocarcinoma Prostatic Neoplasms Prostatic Hyperplasia Lung Neoplasms Pancreatic Neoplasms Neoplasms, Hormone-Dependent Neoplasm Metastasis Disease Progression Stomach Neoplasms Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Adenocarcinoma, Mucinous Esophageal Neoplasms Colonic Neoplasms Bone Neoplasms Carcinoma, Pancreatic Ductal Genetic Predisposition to Disease Adenocarcinoma, Papillary Barrett Esophagus Adenocarcinoma, Bronchiolo-Alveolar Breast Neoplasms Carcinoma Ovarian Neoplasms Neoplasm Recurrence, Local Neoplasms Carcinoma, Squamous Cell Cell Transformation, Neoplastic Colorectal Neoplasms Endometrial Neoplasms Prostatic Neoplasms, Castration-Resistant Precancerous Conditions Rectal Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Prostatic Diseases Neoplasms, Multiple Primary Neovascularization, Pathologic Prostatitis Mammary Neoplasms, Experimental Urinary Bladder Neoplasms Disease Models, Animal Lymphatic Metastasis Intestinal Neoplasms Adenoma Carcinoma, Endometrioid Neoplasms, Experimental Carcinoma, Small Cell Gastrointestinal Neoplasms Carcinoma in Situ Adenocarcinoma, Clear Cell Carcinoma, Signet Ring Cell

Chemicals and Drugs67

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Tosyl Compounds RNA, Messenger Antineoplastic Agents, Hormonal Androgen Receptor Antagonists Anilides DNA, Neoplasm Dihydrotestosterone Finasteride RNA, Small Interfering Anticarcinogenic Agents Antigens, Neoplasm Metribolone Flutamide Taxoids Cancer Vaccines PTEN Phosphohydrolase Tumor Suppressor Protein p53 Glutamate Carboxypeptidase II Antineoplastic Agents, Phytogenic RNA, Neoplasm 5-alpha Reductase Inhibitors Testosterone Congeners Proto-Oncogene Proteins c-akt Transcription Factors Receptor, Epidermal Growth Factor Testosterone Tumor Suppressor Proteins Racemases and Epimerases Proto-Oncogene Proteins MicroRNAs Nitriles Receptor, erbB-2 Androstenols Antibodies, Monoclonal 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Phenylthiohydantoin Keratin-7 DNA-Binding Proteins Ki-67 Antigen Fluorouracil Glutathione S-Transferase pi Estramustine Leuprolide Receptors, Estrogen Cisplatin Proto-Oncogene Proteins c-bcl-2 Cholestenone 5 alpha-Reductase DNA Primers Goserelin Cadherins Nuclear Proteins Paclitaxel Enzyme Inhibitors Carcinoembryonic Antigen Androgen-Binding Protein Deoxycytidine Membrane Proteins Trans-Activators Oncogene Proteins, Fusion

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Prostatectomy Orchiectomy Neoplasm Staging Early Detection of Cancer Immunohistochemistry Prognosis Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Risk Factors Xenograft Model Antitumor Assays Transplantation, Heterologous Gene Expression Profiling Survival Rate Case-Control Studies Blotting, Western Survival Analysis Biopsy Retrospective Studies Digital Rectal Examination Follow-Up Studies Tissue Array Analysis Treatment Outcome Prospective Studies Sensitivity and Specificity Biopsy, Needle Risk Transurethral Resection of Prostate Risk Assessment Oligonucleotide Array Sequence Analysis Combined Modality Therapy Incidence Immunoenzyme Techniques Kaplan-Meier Estimate Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Tumor Burden Odds Ratio Polymerase Chain Reaction Transfection Cohort Studies Predictive Value of Tests Multivariate Analysis Brachytherapy SEER Program Drug Screening Assays, Antitumor Castration Registries Radiotherapy Reproducibility of Results Radiotherapy Dosage Molecular Targeted Therapy Logistic Models Mammary Neoplasms, Experimental Disease Models, Animal Nomograms In Situ Hybridization, Fluorescence Radiotherapy, Conformal Flow Cytometry Gene Knockdown Techniques Chemotherapy, Adjuvant Questionnaires Models, Biological Confidence Intervals Mass Screening Proportional Hazards Models Clinical Trials as Topic Tomography, X-Ray Computed Neoplasms, Experimental DNA Mutational Analysis Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Signal Transduction Drug Resistance, Neoplasm Cell Division Sensitivity and Specificity Cell Growth Processes Risk Down-Regulation Cell Survival Mutation Genotype DNA Methylation Time Factors Odds Ratio Up-Regulation Cell Movement Transfection Promoter Regions, Genetic Cell Cycle Dose-Response Relationship, Drug Polymorphism, Genetic Genes, Tumor Suppressor Gene Silencing Base Sequence Gene Expression RNA Interference Nomograms Chromosomes, Human, Pair 8 Gene Fusion Phosphorylation Polymorphism, Single Nucleotide Genes, ras Alleles Genes, Neoplasm Transcription, Genetic Diet Loss of Heterozygosity Phenotype Drug Synergism Germ-Line Mutation Genes, p53

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence SEER Program Registries Base Sequence Molecular Sequence Data Radiotherapy, Conformal Questionnaires

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care31

Risk Factors Survival Rate Case-Control Studies Survival Analysis Retrospective Studies Follow-Up Studies Watchful Waiting Treatment Outcome Prospective Studies Sensitivity and Specificity Risk Risk Assessment Incidence Kaplan-Meier Estimate Disease-Free Survival Odds Ratio Cohort Studies Predictive Value of Tests Multivariate Analysis SEER Program Age Factors Registries Reproducibility of Results National Cancer Institute (U.S.)Logistic Models Nomograms Questionnaires Confidence Intervals Mass Screening Proportional Hazards Models Clinical Trials as Topic

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Adenocarcinoma Prostate Prostatic Neoplasms Prostate-Specific Antigen Cell Line, Tumor Receptors, Androgen Androgens Androgen Antagonists Prostatectomy Gene Expression Regulation, Neoplastic Tumor Markers, Biological Prostatic Hyperplasia Lung Neoplasms Orchiectomy Pancreatic Neoplasms Neoplasms, Hormone-Dependent Neoplasm Metastasis Mice, Nude Disease Progression Neoplasm Staging Stomach Neoplasms Early Detection of Cancer Immunohistochemistry Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Adenocarcinoma, Mucinous Prognosis Esophageal Neoplasms Tumor Cells, Cultured Cell Proliferation Colonic Neoplasms Neoplasm Proteins Antineoplastic Agents Neoplasm Grading Tosyl Compounds Reverse Transcriptase Polymerase Chain Reaction Bone Neoplasms Apoptosis Neoplasm Transplantation RNA, Messenger Carcinoma, Pancreatic Ductal Genetic Predisposition to Disease Risk Factors Adenocarcinoma, Papillary Xenograft Model Antitumor Assays Antineoplastic Agents, Hormonal Transplantation, Heterologous Barrett Esophagus Gene Expression Profiling Androgen Receptor Antagonists Survival Rate Adenocarcinoma, Bronchiolo-Alveolar Case-Control Studies Breast Neoplasms Blotting, Western Survival Analysis Carcinoma Biopsy Retrospective Studies Anilides Digital Rectal Examination DNA, Neoplasm Ovarian Neoplasms Neoplasm Recurrence, Local Neoplasms Dihydrotestosterone Signal Transduction Follow-Up Studies Tissue Array Analysis Watchful Waiting Treatment Outcome Drug Resistance, Neoplasm Finasteride Cell Division Prospective Studies Sensitivity and Specificity Cell Growth Processes RNA, Small Interfering Biopsy, Needle Risk Cardia Carcinoma, Squamous Cell Transurethral Resection of Prostate Down-Regulation Anticarcinogenic Agents Antigens, Neoplasm Metribolone Risk Assessment Cell Survival Oligonucleotide Array Sequence Analysis Cell Transformation, Neoplastic Mutation Combined Modality Therapy Colorectal Neoplasms Genotype Incidence Flutamide Taxoids Immunoenzyme Techniques Kaplan-Meier Estimate

No FAQ available that match "prostate cancer poorly differentiated adenocarcinoma"